This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
CVS Health (CVS) Releases Encouraging Flu Shot Survey Data
by Zacks Equity Research
CVS Health's (CVS) survey on flu vaccination came up with positive outcome. The data confirms untapped opportunities in the flu vaccine market.
Cigna Hits 52-Week High On Strong Q2 Results, Upbeat View
by Zacks Equity Research
Cigna (CI) shares rally to 52-week high as strong second-quarter results, guidance increase and recent developments cheer investors.
Cigna (CI) Earnings Beat in Q2, Guidance Raised, Shares Gain
by Zacks Equity Research
Higher revenues, strength in its Global HealthCare segment and membership growth drive an earnings beat at Cigna (CI) in Q2.
Cigna Corp.'s (CI) Q2 Earnings and Revenues Beat, Guides Up
by Sapna Bagaria
Higher revenues, strength in its Global HealthCare segment and membership growth drive earnings beat at Cigna (CI) in Q2.
3 Reasons Why Cigna Corporation (CI) Is Poised To Beat Earnings
by Jeffrey Hymen
Cigna currently sports a Zacks Rank #2 (Buy) and has defeated its earnings projections in twelve of its past thirteen operational quarters, including an impressive beat last quarter of 13.52%.
Insurance Stocks' Aug 4 Q2 Earnings Roster: BRK.B, CI, AON
by Zacks Equity Research
Core business growth, higher premiums and an improving rate environment are likely to benefit insurers. However, volatile underwriting due to catastrophe losses raises concern.
Should You Buy Cigna Corporation (CI) Ahead of Earnings?
by Zacks Equity Research
Cigna Corporation (CI) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP.
Aon plc (AON) to Report Q2 Earnings: What's in the Cards?
by Zacks Equity Research
Aon plc's (AON) second-quarter earnings are likely to be driven by strong performance across its five revenue lines.
Top Ranked Growth Stocks to Buy for August 1st
by Zacks Equity Research
Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, August 1st:
Prudential Financial (PRU) Q2 Earnings: What's in the Cards?
by Zacks Equity Research
Higher expenses might restrict Prudential's (PRU) top-line improvement to upset its performance in Q2.
Top Ranked Growth Stocks to Buy for July 26th
by Zacks Equity Research
Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, July 26th:
HCA Healthcare (HCA) Q2 Earnings & Revenues Lag, Stock Dips
by Zacks Equity Research
Earnings miss at HCA Healthcare, Inc. (HCA) can be traced back to an increase in expenses, which outpaced revenue growth.
UnitedHealth (UNH) Beats on Q2 Earnings, Guides Up for 2017
by Zacks Equity Research
Higher revenues, strength in UnitedHealthcare and Optum segments and membership growth drive earnings beat at UnitedHealth Group Inc. (UNH) in Q2.
Why it is Apt to Hold Prudential Financial (PRU) Stock Now
by Zacks Equity Research
Prudential Financial (PRU) continues to impress with its solid product and service portfolio, inorganic growth as well as robust capital and liquidity position.
Visa (V) Gearing Up for Q3 Earnings: Is a Surprise in Store?
by Zacks Equity Research
We expect fiscal third-quarter earnings of Visa Inc. (V) to gain traction from its digital initiatives.
UnitedHealth Faces Moody's Rating Action, Outlook Upgraded
by Zacks Equity Research
UnitedHealth (UNH) rating action by Moody's takes into account the company's its leadership position in the industry, its diversified business product profile.
UnitedHealth (UNH) to Report Q2 Earnings: What to Expect
by Zacks Equity Research
Our proven model does not conclusively show that UnitedHealth (UNH) is likely to beat on earnings this quarter.
MGIC Investment (MTG) Posts Solid June Business Statistics
by Zacks Equity Research
MGIC Investment's (MTG) insurance in force for the month was $187.3 billion, up 5.5% year over year.
Cigna (CI) Hits 52-Week High on Recent Buyout, Growth Plans
by Zacks Equity Research
The stock of Cigna (CI) hit a 52-week high of $173.44. The rise in the stock is believed to have been driven by an acquisition, its detailed long-term growth plans.
Intercontinental Exchange (ICE) on Growth Path: Time to Buy?
by Zacks Equity Research
Shares of Intercontinental Exchange have rallied 16.75% year to date, outperforming the Zacks categorized Securities Exchange industry's increase of 13.12%.
CNA Financial's (CNA) Expenses Rise: Time to Dump the Stock?
by Zacks Equity Research
CNA Financial Corporation (CNA) has been witnessing escalating expenses over the past few years and the property and casualty (P&C) insurer does not expect a change anytime soon.
Cigna Buys Zurich Insurance to Expand in UAE, Shares Gain
by Zacks Equity Research
Cigna Corp. (CI) has acquired Zurich Insurance Middle East. The deal which was completed last month will provide Cigna a stronger foothold in the Gulf countries.
Horace Mann's (HMN) Q2 Catastrophe Loss May Hit Bottom Line
by Zacks Equity Research
Horace Mann Educators Corp. (HMN) has estimated to incur a pre-tax catastrophe loss between $31 million and $34 million for second-quarter 2017.
Here's Why You Should Dump CME Group (CME) Stock for Now
by Zacks Equity Research
Shares of CME Group gained 7.59% year to date, underperforming the Zacks categorized Securities and Exchanges industry's gain of 13.83%.
Assurant's $1.36B Reinsurance Program to Curb Financial Risk
by Zacks Equity Research
Assurant (AIZ) has announced a $1.36 billion 2017 property catastrophe reinsurance program, intended to lower its risk and financial exposure, thereby augmenting financial capabilities.